A 68-year-old man from rural Maharashtra presents with a non-healing ulcer on his left ear for 8 months. He is a farmer with chronic sun exposure. On examination, the lesion is 2 cm × 1.5 cm, indurated, with rolled edges, central ulceration, and surrounding erythema. There is ipsilateral cervical lymphadenopathy. A biopsy shows infiltrating nests of malignant squamous cells with moderate differentiation and keratin pearl formation. Which of the following is the most important prognostic factor that will influence his treatment and survival?

Explanation

## Prognostic Factors in Cutaneous Squamous Cell Carcinoma ### Key Prognostic Determinants **High-Yield:** Lymph node involvement is the single most important prognostic factor in cutaneous SCC, dramatically worsening prognosis and altering treatment from local excision to wide excision plus lymphadenectomy ± adjuvant therapy [cite:Robbins 10e Ch 25]. **Key Point:** The presence of regional lymph node metastases (N1–N3 disease) reduces 5-year survival from ~95% (N0 disease) to ~40–50%, making nodal status the most critical staging and prognostic variable. ### Staging and Prognostic Hierarchy | Factor | Impact on Prognosis | Clinical Significance | |--------|---------------------|----------------------| | **Lymph node involvement** | Highest — defines stage III/IV | Mandates lymphadenectomy, systemic therapy | | **Depth of invasion (Clark/Breslow)** | High — T-stage determinant | >4 mm or Clark IV–V increases nodal risk | | **Histological grade** | Moderate — affects local recurrence | Poor differentiation increases metastatic risk | | **Lesion size** | Moderate — T-stage component | >2 cm increases risk, but less critical than nodal status | | **Location (ear, lip)** | Moderate — site-specific risk | Ear/lip have higher recurrence and metastatic rates | | **Age and sun exposure** | Low — non-modifiable risk factors | Do not alter treatment or prognosis once diagnosed | ### Clinical Decision-Making In this case, the presence of **ipsilateral cervical lymphadenopathy** indicates: 1. **Regional metastasis** — upstages the disease to Stage III (AJCC). 2. **Treatment shift** — from local excision alone to **wide local excision + ipsilateral neck dissection** (modified radical or selective based on imaging). 3. **Adjuvant consideration** — high-risk features (nodal disease + ear location + moderate differentiation) may warrant postoperative radiotherapy. 4. **Survival impact** — 5-year survival drops to ~40–50% with nodal involvement vs. >90% for node-negative disease. **Clinical Pearl:** Ear and lip SCC have inherently higher metastatic potential (5–10% nodal involvement at presentation) compared to trunk/extremity SCC (~2–3%), so nodal assessment is mandatory in these high-risk sites. ### Why Other Factors Are Secondary - **Histological grade & Clark level** — important for T-staging and local recurrence risk, but do not override the prognostic weight of nodal involvement. - **Patient age & occupational history** — risk factors for development, not prognostic modifiers once disease is present. - **Lesion size** — contributes to T-stage but is less critical than N-stage in determining survival and treatment intensity.